ATE280182T1 - Inaktivierter impfstoff gegen katzen calicivirus - Google Patents

Inaktivierter impfstoff gegen katzen calicivirus

Info

Publication number: ATE280182T1
Authority: AT; Austria
Prior art keywords: vaccine against; inactivated vaccine; against calicivirus; calicivirus; inactivated
Prior art date: 1999-07-16

Application number

AT00953242T

Other languages

English (en)

Inventor

Herve Poulet

Sylvain Gabriel Goutebroze

Original Assignee

Merial Sas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-16

Filing date

2000-07-13

Publication date

2004-11-15

1999-07-16 Priority claimed from FR9909420A external-priority patent/FR2796281B1/fr

2000-07-13 Application filed by Merial Sas filed Critical Merial Sas

2004-11-15 Application granted granted Critical

2004-11-15 Publication of ATE280182T1 publication Critical patent/ATE280182T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/106—Picornaviridae (F), e.g. hepatitis A virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16061—Methods of inactivation or attenuation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16061—Methods of inactivation or attenuation
- C12N2770/16063—Methods of inactivation or attenuation by chemical treatment

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Engineering & Computer Science (AREA)
Oncology (AREA)
Biotechnology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

AT00953242T 1999-07-16 2000-07-13 Inaktivierter impfstoff gegen katzen calicivirus ATE280182T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR9909420A FR2796281B1 (fr)	1999-07-16	1999-07-16	Vaccin inactive contre la calicivirose feline
FR0001759A FR2796282B1 (fr)	1999-07-16	2000-02-11	Vaccin inactive contre la calicivirose feline
PCT/FR2000/002050 WO2001005835A1 (fr)	1999-07-16	2000-07-13	Vaccin inactive contre la calicivirose feline

Publications (1)

Publication Number	Publication Date
ATE280182T1 true ATE280182T1 (de)	2004-11-15

Family

ID=26212168

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00953242T ATE280182T1 (de)	1999-07-16	2000-07-13	Inaktivierter impfstoff gegen katzen calicivirus

Country Status (17)

Country	Link
EP (1)	EP1194450B1 (de)
JP (1)	JP4841775B2 (de)
KR (3)	KR100859824B1 (de)
AR (1)	AR024770A1 (de)
AT (1)	ATE280182T1 (de)
AU (1)	AU6576400A (de)
BR (1)	BR0012500B1 (de)
CA (1)	CA2378802C (de)
DE (1)	DE60015127T2 (de)
DK (1)	DK1194450T3 (de)
ES (1)	ES2231233T3 (de)
FR (1)	FR2796282B1 (de)
HU (1)	HU228430B1 (de)
MX (1)	MXPA02000536A (de)
PL (1)	PL205298B1 (de)
PT (1)	PT1194450E (de)
WO (1)	WO2001005835A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7850978B2 (en) *	1999-07-16	2010-12-14	Merial Limited	Vaccine against feline calicivirus
US20040161741A1 (en)	2001-06-30	2004-08-19	Elazar Rabani	Novel compositions and processes for analyte detection, quantification and amplification
DK1734992T3 (da) *	2004-01-21	2011-12-05	Merial Ltd	Forbedrede inaktiverede FCV-vacciner
ATE496629T1 (de) *	2005-07-28	2011-02-15	Pfizer Prod Inc	Impfstoff gegen felines calicivirus (fcv), der ein fcv kapsid protein oder ein isoliertes fcv kapsid protein mit der protein sequenz seq id no: 13 oder mit einer protein sequenz, die zumindestens zu 95 identisch zur seq id no: 13 ist enthält.
KR102796617B1 (ko) *	2022-07-14	2025-04-24	대한민국	고양이 바이러스 감염 질병의 예방 또는 경감용 조성물 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE119545T1 (de) *	1989-07-21	1995-03-15	Upjohn Co	Felincalicivirus-capsid-protein und nukleotidsequenz.
JP3514482B2 (ja) *	1992-02-28	2004-03-31	財団法人化学及血清療法研究所	抗ネコカリシウイルス組換え抗体および該抗体からなる治療剤
US6231863B1 (en) *	1997-06-10	2001-05-15	American Cyanamid Company	DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same

2000
- 2000-02-11 FR FR0001759A patent/FR2796282B1/fr not_active Expired - Lifetime
- 2000-07-13 EP EP00953242A patent/EP1194450B1/de not_active Expired - Lifetime
- 2000-07-13 KR KR1020027000615A patent/KR100859824B1/ko not_active Expired - Lifetime
- 2000-07-13 PT PT00953242T patent/PT1194450E/pt unknown
- 2000-07-13 DK DK00953242T patent/DK1194450T3/da active
- 2000-07-13 WO PCT/FR2000/002050 patent/WO2001005835A1/fr not_active Ceased
- 2000-07-13 AT AT00953242T patent/ATE280182T1/de not_active IP Right Cessation
- 2000-07-13 DE DE60015127T patent/DE60015127T2/de not_active Expired - Lifetime
- 2000-07-13 MX MXPA02000536A patent/MXPA02000536A/es active IP Right Grant
- 2000-07-13 JP JP2001511492A patent/JP4841775B2/ja not_active Expired - Lifetime
- 2000-07-13 ES ES00953242T patent/ES2231233T3/es not_active Expired - Lifetime
- 2000-07-13 BR BRPI0012500-8A patent/BR0012500B1/pt not_active IP Right Cessation
- 2000-07-13 AU AU65764/00A patent/AU6576400A/en not_active Abandoned
- 2000-07-13 PL PL352461A patent/PL205298B1/pl unknown
- 2000-07-13 KR KR1020087001920A patent/KR20080012405A/ko not_active Ceased
- 2000-07-13 KR KR1020097000095A patent/KR100934687B1/ko not_active Expired - Lifetime
- 2000-07-13 CA CA2378802A patent/CA2378802C/en not_active Expired - Lifetime
- 2000-07-13 HU HU0202389A patent/HU228430B1/hu unknown
- 2000-07-17 AR ARP000103658A patent/AR024770A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE60015127T2 (de)	2005-10-13
PL352461A1 (en)	2003-08-25
BR0012500A (pt)	2002-04-02
HUP0202389A2 (hu)	2002-12-28
DK1194450T3 (da)	2005-02-21
AR024770A1 (es)	2002-10-23
JP4841775B2 (ja)	2011-12-21
ES2231233T3 (es)	2005-05-16
JP2003505400A (ja)	2003-02-12
FR2796282A1 (fr)	2001-01-19
AU6576400A (en)	2001-02-05
CA2378802C (en)	2012-01-24
HUP0202389A3 (en)	2003-12-29
DE60015127D1 (de)	2004-11-25
KR100934687B1 (ko)	2009-12-31
MXPA02000536A (es)	2002-07-30
PT1194450E (pt)	2005-03-31
BR0012500B1 (pt)	2011-03-22
CA2378802A1 (en)	2001-01-25
KR100859824B1 (ko)	2008-09-23
FR2796282B1 (fr)	2001-10-26
PL205298B1 (pl)	2010-04-30
KR20020020785A (ko)	2002-03-15
EP1194450B1 (de)	2004-10-20
EP1194450A1 (de)	2002-04-10
KR20090007803A (ko)	2009-01-20
HU228430B1 (en)	2013-03-28
WO2001005835A1 (fr)	2001-01-25
KR20080012405A (ko)	2008-02-11

Legal Events

Date	Code	Title	Description
2005-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60024893D1 (de)	2006-01-19	Impfstoff gegen HPV
NO20014323D0 (no)	2001-09-05	Vaksine
CY2011008I2 (el)	2014-04-09	Εμβολιο γριπης
NO20021433D0 (no)	2002-03-21	Vaksiner
NO20024172D0 (no)	2002-09-02	Vaksine
DE69923434D1 (de)	2005-03-03	Adjuvierte rekombinante Lebendimpfstoffe gegen Influenza- oder Herpesviren
PL363005A1 (pl)	2004-11-15	Szczepionki
EP1458242A4 (de)	2006-06-07	Polyvalente konjugatvakzine gegen krebs
EP1307130A4 (de)	2005-01-12	Impfstoff gegen menschlichen immunschwächevirus
DK1427444T3 (da)	2013-11-04	West-nil-vaccine
NO20020763L (no)	2002-04-16	Vaksine
DK1265633T3 (da)	2013-01-07	Vaccineadjuvans
NO20033882D0 (no)	2003-09-02	Vaksine
EP1423141A4 (de)	2005-08-03	Vakzine
NO20052149D0 (no)	2005-05-02	Vaksine.
BR0012512B1 (pt)	2011-05-17	genes de calicivìrus felino e vacinas notadamente vacinas recombinadas.
DE60226218D1 (de)	2008-06-05	Impfstoff gegen pferdeherpesvirus
DE60125927D1 (de)	2007-02-22	Impfstoffe gegen hiv
DE60015127D1 (de)	2004-11-25	Inaktivierter impfstoff gegen katzen calicivirus
EP1105154A4 (de)	2005-03-09	Impfstoffe gegen bakterielle superantigene
IS6184A (is)	2001-11-29	Bóluefni gegn ISA veiru
ATE333894T1 (de)	2006-08-15	Vakzine gegen infektiöse bursitis
ATE346870T1 (de)	2006-12-15	Natürlicher antikörper mit wirkung gegen das hiv virus
EP1487852A4 (de)	2006-02-22	Impfstoff mit wirkung gegen protozoen
ATA6762000A (de)	2001-05-15	Zahnärztliches oder chirurgisches winkelstück